سعر Parkicarlevo 250/25 mg tablets 2026

Levodopa 250 mg / carbidopa 25 mg oral tablets for parkinsonism, pack of 30.

• Parkinson's disease, post-encephalitic parkinsonism and symptomatic parkinsonism after carbon monoxide or manganese intoxication.Population: AdultsDailyMed (US National Library of Medicine)

• Most common adverse reactions: dyskinesias (choreiform, dystonic and other involuntary movements) and nausea.International label, same formulation · DailyMed (US National Library of Medicine)

• Contraindicated with non-selective MAO inhibitors (stop them at least two weeks before starting); in known hypersensitivity to any component; and in narrow-angle glaucoma.International label, same formulation · DailyMed (US National Library of Medicine)

• Dyskinesias may occur at lower doses and sooner than with levodopa alone; observe patients for depression with suicidal tendencies; levodopa must be stopped at least 12 hours before switching to the combination.International label, same formulation · DailyMed (US National Library of Medicine)

• Non-selective MAO inhibitorsContraindicated; discontinue at least two weeks before starting therapy.DailyMed (US National Library of Medicine)

• Carbidopa-levodopa caused visceral and skeletal malformations in rabbits; no adequate and well-controlled studies in pregnant women.International label, same formulation · DailyMed (US National Library of Medicine)
• Levodopa has been detected in human milk; use caution in nursing women.International label, same formulation · DailyMed (US National Library of Medicine)

• Levodopa: Crosses the blood-brain barrier and is decarboxylated to dopamine in the brain.
• Carbidopa: Inhibits peripheral decarboxylation of levodopa so that more levodopa reaches the brain.